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Abstract
Human AlkB homolog 2 (ALKBH2) is a DNA repair enzyme that catalyzes the direct reversal of 
DNA methylation damage through oxidative demethylation. While ALKBH2 colocalizes with 
proliferating cell nuclear antigen (PCNA) in DNA replication foci, it remains unknown whether 
these two proteins alone form a complex or require additional components for interaction. Here, 
we demonstrate that ALKBH2 can directly interact with PCNA independent from other cellular 
factors, and we identify the hydrophobic pocket of PCNA as the key domain mediating this 
interaction. Moreover, we find that PCNA association with ALKBH2 increases significantly 
during DNA replication, suggesting that ALKBH2 forms a cell-cycle dependent complex with 
PCNA. Intriguingly, we show that an ALKBH2 germline variant, as well as a variant found in 
cancer, display altered interaction with PCNA. Our studies reveal the ALKBH2 binding interface 
of PCNA and indicate that both germline and somatic ALKBH2 variants could have cellular 
effects on ALKBH2 function in DNA repair.
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Escherichia coli AlkB is a DNA repair enzyme that represents the founding member of the 
AlkB family of non-heme iron-dependent dioxygenases (reviewed in [1]). The human 
genome encodes nine AlkB homologs termed AlkB homolog 1 through 8 (ALKBH1 
through 8) plus a ninth member termed fat mass and obesity associated (FTO). Bacterial 
AlkB as well as human ALKBH2 and ALKBH3 catalyze the direct reversal of DNA 
methylation damage through a distinct oxidative demethylation reaction [2–5]. Importantly, 
ALKBH2 has been shown to play a role in DNA alkylation damage repair in human, mouse 
and plant cells [6–8].
Proliferating cellular nuclear antigen (PCNA) is the major eukaryotic DNA sliding clamp for 
both replicative and translesion DNA polymerases [9]. In addition to DNA polymerases, 
PCNA interacts with numerous proteins involved in DNA damage signaling and repair, cell 
cycle progression and the cellular stress response (reviewed in [10]). Many PCNA-
interacting proteins such as p21, flap structure-specific endonuclease 1 and replication factor 
Ccontain a well-characterized PCNA-interacting protein (PIP) box motif that binds to a 
hydrophobic pocket in PCNA [9]. Importantly, the interaction between PCNA and the PIP 
box-containing proteins is regulated through post-translational modifications such as 
phosphorylation and ubiquitination [10].
In addition to the PIP box, the ALKBH2-PCNA interacting motif (APIM) represents anewly 
discovered PCNA-interacting domain found in numerous proteins that are required for 
coordination of DNA replication and repair [11]. The APIM sequence is found in the first 
seven amino acid residues of ALKBH2 and is required for close association between 
ALKBH2 and PCNA [11, 12]. In addition to ALKBH2, numerous other DNA repair 
proteins contain an APIM motif that is required for proper protein function in DNA repair 
pathways such as homologous recombination and nucleotide excision repair [13–15]. While 
an interaction between a subset of APIM-containing proteins and PCNA has been 
demonstrated, the specific contacts made between APIM-containing proteins with PCNA 
remains unknown.
Here, we demonstrate that human ALKBH2 directly interacts with PCNA through a 
hydrophobic pocket formed by the inter domain connector loop and internal region of 
PCNA. Moreover, we show that ALKBH2 interaction with PCNA is enhanced during S-
phase, indicating a cell cycle dependent interaction. Finally, we find that naturally occurring 
variants of ALKBH2 in cancer cells or the human population can alter PCNA binding. 
Collectively, our results provide insight into the molecular determinants of ALKBH2-PCNA 
interaction and the potential effects caused by ALKBH2 isoforms.
2. Materials And Methods
All Materials and Methods such as recombinant protein expression, purification and analysis 
as well as cell culture and transfection can be found in Supplemental Information.
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3. Results And Discussion
3.1 Mutation of the hydrophobic pocket in PCNA disrupts interaction with ALKBH2
Fluorescence resonance energy transfer (FRET)-based assays in human cells indicate a close 
association between ALKBH2 and PCNA [11]. Thus, we tested whether purified ALKBH2 
and PCNA can interact in the absence of additional factors or modifications. As a control for 
binding specificity, we included ALKBH3, another AlkB homolog that has been shown to 
repair DNA in vitro and in vivo but lacks an APIM sequence [2, 4, 16]. For binding assays, 
purified ALKBH2 or ALKBH3 (Supplemental Figure 1) were pre-incubated with an 
equimolar amount of PCNA followed by binding of the SBP-tagged ALKBH2 or ALKBH3 
to streptavidin resin. Using this assay, we found that PCNA interacts with ALKBH2 while 
no PCNA was detected with the buffer control (Figure 1A). However, we did not detect any 
interaction between PCNA and ALKBH3, consistent with the absence of a PCNA-
interacting motif in ALKBH3. Our results demonstrate a direct and specific interaction 
between ALKBH2 and PCNA.
Previous studies using FRET have suggested a common binding site on PCNA for both PIP-
box containing proteins and APIM-containing proteins [12]. Our in vitro assay for 
measuring a direct interaction between ALKBH2 and PCNA allowed us to dissect the 
requirements for ALKBH2-PCNA interaction. We used a previously characterized panel of 
PCNA mutants to test the potential domains of PCNA that mediate interaction with 
ALKBH2 (Figure 1B) [17]. The PCNA mutants include: SHV43 (Ser43, His44 and Val45 to 
alanine), which disrupts a hydrophobic pocket on the front face of PCNA necessary for 
binding PIP-box containing proteins; QLGI125 (Gln125, Leu126, Gly127, and Ile128 to 
alanine), which disrupts the inter domain connector loop that composes a portion of the 
PCNA hydrophobic pocket; and VDK188 (Val188, Asp189 and Lys188 to alanine), which 
alters an unstructured loop on the backside of the PCNA trimer. While wild-type (WT) 
PCNA displayed robust interaction with ALKBH2, we found that PCNA mutants SHV43 
and QLGI125 are severely deficient in ALKBH2 binding (Figure 1C). In contrast, the 
VDK188 PCNA mutant displayed interaction with ALKBH2 equivalent to that of WT 
PCNA (Figure 1C). Thus, mutation of the hydrophobic pocket of PNCA as well as the 
interdomain connecting loop that forms a portion of the hydrophobic pocket leads to greatly 
reduced interaction between PCNA and ALKBH2. On the other hand, mutations to the 
backside of PCNA appear to have minimal or no effect on ALKBH2 binding.
To confirm these in vitro results, we determined whether the same interaction requirements 
pertain to ALKBH2 and PCNA in human cells. We expressed ALKBH2 in 293T human 
embryonic kidney cells as a fusion protein with the FLAG epitope tag at either the amino- or 
carboxy-terminus. Following purification on anti-FLAG resin, we found that carboxy 
terminal-tagged ALKBH2 displayed interaction with endogenous PCNA while tagging 
ALKBH2 at the amino terminus disrupted interaction with PCNA (Supplemental Figure 
2A). The lack of interaction between amino terminal-tagged ALKBH2 and PCNA is most 
likely due to steric hindrance by the 3xFLAG tag that blocks interaction between the amino-
terminal APIM of ALKBH2 and PCNA. Furthermore, the interaction between ALKBH2 and 
PCNA was resistant to nuclease treatment, ruling out nucleic acids as bridging cofactors 
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(Supplemental Figure 2B). The results are consistent with previous results using GFP-tagged 
ALKBH2 [11] and indicate that overexpressed ALKBH2 displays APIM-dependent 
interactions with PCNA without the need of DNA or RNA.
Next, we tested whether PCNA variants display differential binding to ALKBH2 in cells by 
coexpression of PCNA variants with FLAG-tagged ALKBH2 [18]. The over-expressed 
PCNA contains a His-Myc tag at the C-terminus that allows differentiation from endogenous 
PCNA. Using this strategy, we found that the amount of SHV43 and QLGI125 PCNA 
variants associated with ALKBH2 was greatly reduced relative to WT PCNA (Figure 1D). 
Unlike the pure populations of PCNA variants used for in vitro studies, the PCNA trimer 
associated with AKLBH2 purified from human cells represents a mixture of endogenous and 
transiently expressed PCNA. Thus, the remaining amount of SHV43 and QLGI125 PCNA 
variant associated with ALKBH2 is likely due to incorporation of endogenous PCNA into a 
trimer containing both endogenous and variant PCNA that can associate with ALKBH2.
Overall, these data reveal that the hydrophobic pocket of PCNA as a critical determinant of 
ALKBH2-PCNA interaction both in vitro and in vivo. The identification of a common 
binding site on PCNA for APIM and PIP box-containing proteins suggests that two classes 
of PCNA-interacting proteins can compete for the same site. Future studies will be devoted 
to understanding the interplay between APIM versus PIP box-containing proteins for 
binding to PCNA as well as the exact molecular contacts made between the APIM motif and 
PCNA.
3.2 ALKBH2 displays enhanced interaction with PCNA during S-phase
To gain insight into the dynamics of the ALKBH2-PCNA interaction, we investigated 
whether the two proteins display any changes in association after DNA damage and during 
various phases of the cell cycle. For DNA damage, we chose alkylation damage caused by 
MMS since this agent is known to induce replication-blocking lesions repaired by ALKBH2 
[19, 20]. However, we were unable to detect any differences in PCNA-ALKBH2 interaction 
between untreated or MMS-treated cells (Supplemental Figure 2C). Since DNA replication 
stalling due to alkylation damage is known to trigger PCNA modification, our results 
suggest that PCNA-ALKBH2 interaction is not affected by either alkylation DNA damage or 
damage-induced PCNA modifications.
Previous studies using fluorescent tagged proteins and FRET have shown that ALKBH2 
colocalizes with replication foci containing PCNA [11]. Thus, we examined the ALKBH2-
PCNA interaction throughout the cell cycle to determine if there are any cell cycle-
dependent changes in physical interaction between ALKBH2 and PCNA. For this purpose, 
we purified ALKBH2-FLAG from cells synchronized at different phases of the cell cycle 
using a double thymidine block and quantified the amount of PCNA associated relative to 
purified ALKBH2. Notably, we detected a considerable increase in association between 
ALKBH2 and PCNA at four hours after cell synchronization, which represents the time at 
which the highest number of cells are in S-phase (Figures 2A–C). The amount of PCNA 
associated with ALKBH2 decreases significantly at the eight-hour time point, which 
correlates with cellular exit from S-phase and the beginning of G2/mitosis (Figures 2A–C).
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To provide further evidence that ALKBH2 is associated with PCNA predominantly during 
S-phase, we selectively blocked cells in G1 or G2 by p21 overexpression, which is known to 
arrest cells mainly in G1 along with a fraction in G2 [21]. Indeed, the interaction between 
PCNA and ALKBH2 could be abrogated by p21 overexpression and a fraction of p21 
copurified with ALKBH2 after p21 overexpression (Figure 2D). Thus, p21 overexpression 
could be disrupting the ALKBH2-PCNA interaction by cell cycle arrest in G1/G2 and/or 
direct competition with ALKBH2. Our results demonstrate that the physical association 
between ALKBH2 and PCNA is modulated throughout the cell cycle, potentially through 
modifications on either ALKBH2 or PCNA that are independent of DNA damage [11].
3.3 ALKBH2 variants in cancer cells and the human population perturb PCNA binding
Since PCNA and ALKBH2 exhibit specific and dynamic association in cells, we 
investigated whether there are naturally occurring variants that could affect the PCNA-
ALKBH2 interaction. Based upon the Catalogue of Somatic Mutations In Cancer 
(COSMIC) and Ensembl genome database [22, 23], we identified two ALKBH2 variants 
containing amino acid residue substitutions near the APIM motif (Figure 3A). The first 
variant was identified as a somatic missense mutation in an endometrial tumor resulting in 
an alanine to valine mutation (A9V) (Mutation ID: COSM934680). The second variant is a 
heterozygous allele pair found through genome wide exon sequencing which leads to a 
glutamine to lysine substitution (Q10K) (Reference SNP: rs138073204). The Q10K variant 
was identified as a heterozygous allele pair present at low frequency (0.023%) among 
13,006 individuals of European and African-American ancestry (Exome Variant Server, 
NHLBI GO Exome Sequencing Project) (Supplemental Table 1). Due to their proximity to 
the APIM motif, we tested whether these variants affect binding to PCNA.
Wild-type ALKBH2 or either of the two ALKBH2 variants, A9V or Q10K, was expressed in 
human cells followed by affinity purification and analysis of copurifying PCNA. As a 
control, we included a previously characterized ALKBH2 variant that contains a directed 
mutation of phenylalanine to alanine in the APIM motif (F4A) and lacks interaction with 
PCNA [11]. As expected, the F4A mutation completely abolishes the interaction between 
ALKBH2 and PCNA (Figure 3B). Moreover, the amount of PCNA copurifying with the 
A9V tumor-associated variant of ALKBH2 is slightly but reproducibly decreased relative to 
WT ALKBH2. In striking contrast, we find that the Q10K polymorphic variant of ALKBH2 
leads to significantly increased association with PCNA compared to WT ALKBH2 (Figure 
3B, Q10K). The amount of PCNA copurified with ALKBH2 Q10K is approximately 5-fold 
higher than that with WT ALKBH2. We also note a slower migrating PCNA band that 
copurifies with the ALKBH2 Q10K variant. While the exact nature of the higher molecular 
weight PCNA band is currently unknown, the additional PCNA species could represent an 
acetylated form of PCNA based upon its migration [24]. By using a restriction enzyme-
mediated AlkB DNA repair assay, the ALKBH2 variants display comparable enzymatic 
activity to WT ALKBH2 (Figure 3C and D). Thus, the amino acid residue changes in the 
ALKBH2 variants affect PCNA binding but do not alter in vitro DNA repair activity of the 
purified enzymes. Thus, it appears that naturally occurring ALKBH2 variants alter APIM-
dependent interactions with PCNA, leading to either decreased or increased binding.
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In conclusion, we identify the regions of PCNA and ALKBH2 that are required for 
interaction with each other and uncover a dynamic physical interaction that is modulated by 
the cell cycle. Notably, a germline variant of ALKBH2 (Q10K) leads to an increased PCNA 
binding while a cancer-associated mutation (A9V) leads to decreased PCNA binding. Future 
studies will be devoted to understanding the exact cellular consequences arising from altered 
binding of ALKBH2 variants to PCNA. Moreover, we are investigating additional cancer-
association mutations or naturally-occurring SNPs in ALKBH2 that might affect PCNA 
binding or other aspects of ALKBH2 repair function. Intriguingly, overexpression of GFP 
fusion proteins with the APIM motif can sensitize human cells to chemotherapeutic DNA 
damaging agents [11, 12]. Thus, our studies could provide a novel insight into potential anti-
cancer therapies based upon APIM motifs [25].
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• ALKBH2 directly interacts with PCNA through a hydrophobic pocket.
• PCNA and ALKBH2 associate in cell-cycle dependent manner.
• Naturally-occurring variants of ALKBH2 display altered binding to 
PCNA.
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FIGURE 1. Interaction of ALKBH2 with PCNA through the hydrophobic patch and the inter-
domain connecting loop of PCNA
(A) Immunoblot analysis of input and streptavidin resin from in vitro binding reactions 
containing recombinant ALKBH2 or ALKBH3 with PCNA. ALKBH2 and ALKBH3 
contain a streptavidin binding peptide tag. Buffer represents a control purification containing 
PCNA and buffer but lacking ALKBH2 or ALKBH3. (B) Schematic of PCNA trimer with 
location of mutations found in SHV43, QLGI125 and VDK188 PCNA variants [17]. (C) 
Immunoblot analysis of input and streptavidin resin from binding reactions containing 
ALKBH2 and the indicated PCNA variants. Buffer represents a control purification 
containing wild-type (WT) PCNA and buffer but lacking ALKBH2. (D) Immunoblot 
analysis of input and purified samples from 293T cells expressing ALKBH2-FLAG and the 
indicated PCNA mutants. ALKBH2-FLAG was affinity purified using anti-FLAG resin and 
purifications were analyzed by immunoblotting.(−) represents a negative control purification 
from 293T cells transfected with empty vector.
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FIGURE 2. Enhanced interaction of PCNA with ALKBH2 during S-phase
(A) Cell cycle profiles of 293T cells transfected with ALKBH2-FLAG. “AS” represents an 
asynchronous population and time after the double thymidine block is represented in hours. 
(B) Immunoblot analysis of input and purified samples from 293T cells transfected with 
ALKBH2 at the indicated time points post double thymidine block. Vector represents a 
control purification from 293T cells transfected with empty vector. PCNA fold-enrichment 
was relative to asynchronous and normalized to purified ALKBH2. (C) Immunoblot analysis 
of input and purified samples from 293T cells expressing ALKBH2 with or without p21 
overexpression. The experiment was repeated twice with identical results.
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FIGURE 3. Alteration of PCNA interaction in ALKBH2 variants found in cancer or the human 
population
(A) Schematic representation of the amino terminus of ALKBH2 (amino acid residues 1–
10). The APIM motif is shaded. ALKBH2 variants F4A, A9V and Q10K are indicated by 
arrows. (B) Immunoblot analysis of input and purified samples from 293T cells transfected 
with the indicated ALKBH2 variants. “vec” represents a control purification from 293T cells 
transfected with empty vector. PCNA enrichment was normalized to purified ALKBH2. (C) 
Denaturing gels of DNA products from double-stranded DNA substrates reacted with the 
indicated samples. (D) Quantification of ALKBH2-catalyzed repair. The percent repaired 
substrate represents the amount of repaired product to unrepaired substrate normalized 
against the signal in (−) negative control reactions. Purifications and activity assays were 
performed at least three times with comparable results.
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